Julie Autmizguine

Dr. Julie Autmizguine serves as an Assistant Clinical Professor in the Department of Pediatrics at the Faculty of Medicine, University of Montreal, with secondary affiliation in the Department of Pharmacology. Based at CHU Sainte-Justine in Montreal, she specializes in pediatric infectious diseases with clinical and research expertise spanning pharmacology, epidemiology, and antibiotic therapy for children.

Her educational trajectory includes pediatric infectious disease training at the University of Montreal followed by advanced clinical pharmacology certification at Duke Clinical Research Institute through the American Pediatric Trials Network. This dual foundation enables her translational research bridging clinical practice and pharmacokinetic modeling.

Dr. Autmizguine's research centers on optimizing anti-infective dosing in pediatric populations, particularly for drug-resistant bacterial infections. Her work integrates pharmacokinetic-pharmacodynamic principles with clinical outcomes across neonatal, infant, and adolescent cohorts. Key focus areas include antibiotic penetration in cerebrospinal fluid, osteoarticular infection management, and biologic agent dosing in autoimmune conditions.

Analysis of her publication record reveals consistent methodological rigor in pediatric pharmacometrics, leveraging population modeling and opportunistic clinical data to address dosing gaps. Her studies span critical therapeutic areas including neonatal necrotizing enterocolitis, ventricular shunt infections, and systemic juvenile arthritis—demonstrating cross-disciplinary relevance to infectious disease, rheumatology, and neurology.

Her scientific recognition includes:

• Robert A. Harrington Excellence in Fellowship Award (Duke Clinical Research Institute, 2014)
• Best Presentation at CHU Sainte-Justine Research Day (2012)
• IMS Pharmacology Award (IMS Health Canada, 2002)

With 11 peer-reviewed publications and 3 book chapters, Dr. Autmizguine actively contributes to pediatric pharmacotherapy guidelines. Her 7 conference presentations since 2011 highlight ongoing engagement with the Pediatric Trials Network, where she collaborates on multi-center studies addressing evidence gaps in childhood infectious disease treatment.

She maintains active roles within CHU Sainte-Justine's Infectious Diseases Service and the American Pediatric Trials Network, driving initiatives that translate pharmacokinetic research into clinical protocols for vulnerable pediatric populations.